Omnicell COO’s Timed Sales: Insider Trading Plan Fuels Brief Dip Amid 52‑Week High Surge
Co‑op insider sales at Omnicell reveal a planned liquidity move, not a red flag—investors should weigh the COO’s buy‑low, sell‑high pattern against the firm’s strong healthcare‑tech fundamentals.
3 minutes to read

